SMLR Stock Recent News

Semler Scientific's stock value has fallen from about $150 per share in November of 2021 to around $30 per share. Yet, the company continues to report growth and is profitable. I believe the market has taken the selling too far and is overlooking the company's unique product and intrinsic valuations.

SANTA CLARA, Calif. , July 21, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the second quarter and first half ended June 30, 2022, after the close of U.S. financial markets on Tuesday, August 2, 2022.

The company missed analysts' estimates with its Q1 results.

Semler Scientific, Inc. (NASDAQ:SMLR ) Q1 2022 Earnings Conference Call May 2, 2022 10:30 AM ET Company Participants Douglas Murphy-Chutorian - CEO Dennis Rosenberg - Chief Marketing Officer Andrew Weinstein - SVP, Finance and Accounting Conference Call Participants Brooks O'Neil - Lake Street Capital Markets LLC Marc Wiesenberger - B. Riley Securities, Inc. Operator Good day, and welcome to the Semler Scientific First Quarter 2022 Financial Results Conference Call.

Semler Scientific Inc. (SMLR) delivered earnings and revenue surprises of -19.61% and 5.43%, respectively, for the quarter ended March 2022. Do the numbers hold clues to what lies ahead for the stock?

Semler Scientific has been sold off since its Q3 and Q4 earnings misses, down 67% from November 2021 levels. Semler is tackling massive healthcare problems such as PAD, diabetes, and Alzheimer's.

SANTA CLARA, Calif. , April 19, 2022 /PRNewswire/ -- Semler Scientific, Inc. (Nasdaq: SMLR), a company that provides technology solutions to improve the clinical effectiveness and efficiency of healthcare providers, today announced that it will report financial results for the first quarter ended March 31, 2022, after the close of U.S. financial markets on Monday, May 2, 2022.